Clover Health interim CFO covers RSU tax
Clover Health Investments’ interim CFO Joseph Clay reported a routine tax-withholding transaction related to restricted stock units.
Rhea-AI Filing Summary
Clover Health Investments’ interim CFO Joseph Clay reported a routine tax-withholding transaction related to restricted stock units. On May 16, 2026, 16,942 shares of Class A Common Stock were automatically withheld at $3.47 per share to cover tax obligations from RSU vesting.
The withheld shares reflect 6.25% of the original RSU grant made on February 16, 2024. The remaining RSUs are scheduled to vest quarterly in equal 6.25% installments until February 16, 2028, subject to Joseph Clay’s continued service. After this transaction, he directly holds 1,217,584 Class A shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Class A Common Stock | 16,942 | $3.47 | $59K |
Footnotes (1)
- F1. Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on May 16, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date.
Key Figures
Key Terms
restricted stock units (RSUs) financial
tax obligations financial
vesting financial
Class A Common Stock financial
continued service financial
FAQ
What did Clover Health (CLOV) interim CFO report in this Form 4?
Is the Clover Health (CLOV) interim CFO’s Form 4 an open-market sale?
What is the vesting schedule of the Clover Health (CLOV) RSU grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.